We assessed the expression of SQS/OPN in patients with lung cancer using publicly available cDNA microarray datasets and online survival analysis software to evaluate the ability of the SQS/OPN axis to serve as an independent prognostic factor for patients with lung cancer25. The gene discussed is SPP1; the disease is lung cancer.